Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

Supplementary Table 3. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

<p>ETS family fusions detected in the WCDT samples</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Arian Lundberg (14960817) (author)
Altres autors:	Meng Zhang (14960814) (author), Rahul Aggarwal (14960826) (author), Haolong Li (16799553) (author), Li Zhang (15042695) (author), Adam Foye (14960823) (author), Martin Sjöström (14845882) (author), Jonathan Chou (14957015) (author), Kevin Chang (16799556) (author), Thaidy Moreno-Rodriguez (14960856) (author), Raunak Shrestha (14949693) (author), Avi Baskin (16799559) (author), Xiaolin Zhu (14845885) (author), Alana S. Weinstein (15024909) (author), Noah Younger (16799562) (author), Joshi J. Alumkal (14950518) (author), Tomasz M. Beer (14960862) (author), Kim N. Chi (14960913) (author), Christopher P. Evans (14960898) (author), Martin Gleave (16799565) (author), Primo N. Lara (14960634) (author), Rob E. Reiter (16799568) (author), Matthew B. Rettig (14960880) (author), Owen N. Witte (14960883) (author), Alexander W. Wyatt (14960922) (author), Felix Y. Feng (14845891) (author), Eric J. Small (14962376) (author), David A. Quigley (14957012) (author)
Publicat:	2025
Matèries:	Cancer Cancer Risk Factors Tumor Biology Molecular and Cellular Biology Epigenetics DNA methylation Gene Regulation Oncogenic transcription factors Promoter/enhancer analysis Genitourinary Cancers Prostate cancer Progression, Invasion & Metastasis
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Supplementary Data 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
per: Arian Lundberg (14960817)
Publicat: (2025)

Supplementary Data 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
per: Arian Lundberg (14960817)
Publicat: (2025)

Supplementary Table 1. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
per: Arian Lundberg (14960817)
Publicat: (2025)

Supplementary Table 2. from The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
per: Arian Lundberg (14960817)
Publicat: (2025)

Supplementary Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations
per: John Gallon (15096459)
Publicat: (2025)

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
per: Haowen Jiang (14963613)
Publicat: (2025)

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
per: Haowen Jiang (14963613)
Publicat: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
per: Haowen Jiang (14963613)
Publicat: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
per: Haowen Jiang (14963613)
Publicat: (2025)

Figure 1 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 2 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 3 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 4 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 5 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 6 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Figure 7 from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Supplementary Table from The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
per: Martin Sjöström (14845882)
Publicat: (2025)

Supplementary Table S3 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
per: Wei Cui (16721390)
Publicat: (2025)

Supplementary Table S4 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
per: Wei Cui (16721390)
Publicat: (2025)

Supplementary Table S5 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
per: Wei Cui (16721390)
Publicat: (2025)

Supplementary Table S6 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
per: Wei Cui (16721390)
Publicat: (2025)

Supplementary Table S7 from Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
per: Wei Cui (16721390)
Publicat: (2025)

Supplementary Data 1 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
per: Hong Qiu (14963144)
Publicat: (2025)

Supplementary Data 2 from KDM6A Loss Triggers an Epigenetic Switch That Disrupts Urothelial Differentiation and Drives Cell Proliferation in Bladder Cancer
per: Hong Qiu (14963144)
Publicat: (2025)

Supplementary Tables TS1-23 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
per: Xiaofan Lu (15049989)
Publicat: (2025)

Supplementary Figure S7 from <i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer
per: Katleen Janssens (15053356)
Publicat: (2025)

Supplemental Table S3 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
per: Yeh Wang (14964041)
Publicat: (2025)

Supplemental Table S4 from Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis
per: Yeh Wang (14964041)
Publicat: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
per: Pochung Jordan Chou (14851578)
Publicat: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
per: Pochung Jordan Chou (14851578)
Publicat: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
per: Pochung Jordan Chou (14851578)
Publicat: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
per: Bouchra Tawk (15389486)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Supplementary Data from HAND2 Assists MYCN Enhancer Invasion to Regulate a Noradrenergic Neuroblastoma Phenotype
per: Man Xu (14963249)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ile7ioupu7cd54jfpbobnm9hcd